These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19956394)

  • 21. Tetrahydrocurcumin, Curcumin, and 5-Fluorouracil Effects on Human Esophageal Carcinoma Cells.
    Pendleton EG; Jamasbi RJ; Geusz ME
    Anticancer Agents Med Chem; 2019; 19(8):1012-1020. PubMed ID: 30652650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination Therapy of Lactobacillus plantarum Supernatant and 5-Fluouracil Increases Chemosensitivity in Colorectal Cancer Cells.
    An J; Ha EM
    J Microbiol Biotechnol; 2016 Aug; 26(8):1490-503. PubMed ID: 27221111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells.
    Giri B; Gomes A; Sengupta R; Banerjee S; Nautiyal J; Sarkar FH; Majumdar AP
    Anticancer Res; 2009 Jan; 29(1):395-401. PubMed ID: 19331178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial.
    Irving GR; Iwuji CO; Morgan B; Berry DP; Steward WP; Thomas A; Brown K; Howells LM
    Trials; 2015 Mar; 16():110. PubMed ID: 25872567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin Suppresses Lung Cancer Stem Cells via Inhibiting Wnt/β-catenin and Sonic Hedgehog Pathways.
    Zhu JY; Yang X; Chen Y; Jiang Y; Wang SJ; Li Y; Wang XQ; Meng Y; Zhu MM; Ma X; Huang C; Wu R; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
    Phytother Res; 2017 Apr; 31(4):680-688. PubMed ID: 28198062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure.
    Tsunekuni K; Konno M; Haraguchi N; Koseki J; Asai A; Matsuoka K; Kobunai T; Takechi T; Doki Y; Mori M; Ishii H
    Sci Rep; 2019 Oct; 9(1):14861. PubMed ID: 31619711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin may be a potential adjuvant treatment drug for colon cancer by targeting CD44.
    Fan X; Zhu M; Qiu F; Li W; Wang M; Guo Y; Xi X; Du B
    Int Immunopharmacol; 2020 Nov; 88():106991. PubMed ID: 33182071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Curcumin combined FOLFOX induced cell apoptosis of gastric cancer and its mechanism research].
    Zhou X; You T; Wang WM; Zheng ZQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):810-3. PubMed ID: 23980364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29.
    Du B; Jiang L; Xia Q; Zhong L
    Chemotherapy; 2006; 52(1):23-8. PubMed ID: 16340194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells.
    Yu X; Mi L; Dong J; Zou J
    BMC Cancer; 2017 Nov; 17(1):716. PubMed ID: 29110645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of adjuvant FOLFOX therapy for stage III colon cancer in Japan based on the MOSAIC trial.
    Shiroiwa T; Takeuchi T; Fukuda T; Shimozuma K; Ohashi Y
    Value Health; 2012; 15(2):255-60. PubMed ID: 22433756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microsatellite instability and sensitivitiy to FOLFOX treatment in metastatic colorectal cancer.
    des Guetz G; Mariani P; Cucherousset J; Benamoun M; Lagorce C; Sastre X; Le Toumelin P; Uzzan B; Perret GY; Morere JF; Breau JL; Fagard R; Schischmanoff PO
    Anticancer Res; 2007; 27(4C):2715-9. PubMed ID: 17695437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs.
    Manupati K; Dhoke NR; Debnath T; Yeeravalli R; Guguloth K; Saeidpour S; De UC; Debnath S; Das A
    FEBS J; 2017 Jun; 284(12):1830-1854. PubMed ID: 28398698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemoresistance to 5-FU inhibited by 635 nm LED irradiation in CD133+ KB cell line.
    Kim D; Park M; Jang H; Hyun H; Lim W
    Lasers Med Sci; 2018 Jan; 33(1):57-66. PubMed ID: 28956217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer.
    Chang CW; Lee HC; Li LH; Chiang Chiau JS; Wang TE; Chuang WH; Chen MJ; Wang HY; Shih SC; Liu CY; Tsai TH; Chen YJ
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II-III colorectal cancer.
    Angitapalli R; Litwin AM; Kumar PR; Nasser E; Lombardo J; Mashtare T; Wilding GE; Fakih MG
    Oncology; 2009; 76(5):363-8. PubMed ID: 19321964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
    Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin.
    Nagourney RA; Evans S; Tran PH; Nagourney AJ; Sugarbaker PH
    Eur J Surg Oncol; 2021 Apr; 47(4):738-742. PubMed ID: 33004272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
    Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K
    Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status and future prospective of Curcumin as a potential therapeutic agent in the treatment of colorectal cancer.
    Jalili-Nik M; Soltani A; Moussavi S; Ghayour-Mobarhan M; Ferns GA; Hassanian SM; Avan A
    J Cell Physiol; 2018 Sep; 233(9):6337-6345. PubMed ID: 29219177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.